JP2004537252A5 - - Google Patents

Download PDF

Info

Publication number
JP2004537252A5
JP2004537252A5 JP2001537498A JP2001537498A JP2004537252A5 JP 2004537252 A5 JP2004537252 A5 JP 2004537252A5 JP 2001537498 A JP2001537498 A JP 2001537498A JP 2001537498 A JP2001537498 A JP 2001537498A JP 2004537252 A5 JP2004537252 A5 JP 2004537252A5
Authority
JP
Japan
Prior art keywords
polypeptide
cell
isolated
cells
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001537498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004537252A (ja
Filing date
Publication date
Priority claimed from US09/439,313 external-priority patent/US6329505B1/en
Application filed filed Critical
Priority claimed from PCT/US2000/030904 external-priority patent/WO2001034802A2/fr
Publication of JP2004537252A publication Critical patent/JP2004537252A/ja
Publication of JP2004537252A5 publication Critical patent/JP2004537252A5/ja
Pending legal-status Critical Current

Links

Images

JP2001537498A 1999-11-12 2000-11-09 前立腺癌の治療及び診断のための組成物及び方法 Pending JP2004537252A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/439,313 US6329505B1 (en) 1997-02-25 1999-11-12 Compositions and methods for therapy and diagnosis of prostate cancer
US44368699A 1999-11-18 1999-11-18
PCT/US2000/030904 WO2001034802A2 (fr) 1999-11-12 2000-11-09 Compositions et methodes de traitement et de diagnostic du cancer de la prostate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009017430A Division JP2009142284A (ja) 1999-11-12 2009-01-29 前立腺癌の治療および診断のための組成物および方法

Publications (2)

Publication Number Publication Date
JP2004537252A JP2004537252A (ja) 2004-12-16
JP2004537252A5 true JP2004537252A5 (fr) 2008-05-22

Family

ID=27032000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001537498A Pending JP2004537252A (ja) 1999-11-12 2000-11-09 前立腺癌の治療及び診断のための組成物及び方法

Country Status (5)

Country Link
EP (1) EP1230364A2 (fr)
JP (1) JP2004537252A (fr)
AU (1) AU1656501A (fr)
CA (1) CA2391369A1 (fr)
WO (1) WO2001034802A2 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6657056B2 (en) 1997-02-25 2003-12-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
ES2402947T3 (es) 1997-04-10 2013-05-10 Stichting Katholieke Universiteit University Medical Centre Nijmegen PCA3, genes PCA3 y métodos de uso
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
DK1086223T3 (da) 1998-06-01 2009-11-30 Agensys Inc Nye serpentintransmembranantigener udtrykt i humane cancerformer og anvendelser deraf
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
ATE321857T1 (de) 1999-09-29 2006-04-15 Diagnocure Inc Pca3 mrna in gutartigen und bösartigen prostatageweben
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
CA2386854A1 (fr) * 1999-10-07 2001-04-12 Corixa Corporation Utilisation d'une sequence codante de mycobacterium tuberculosis pour favoriser une expression stable et de fort rendement de proteines heterologues
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
BR0107643A (pt) * 2000-01-14 2003-06-10 Corixa Corp Composições e processos para a terapia e diagnóstico de c ncer de próstata
AU2001249549A1 (en) * 2000-03-27 2001-10-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20020009455A1 (en) * 2000-04-27 2002-01-24 Ted Lau DNA encoding a novel PROST 03 polypeptide
CA2413959C (fr) 2000-06-20 2015-07-07 Corixa Corporation Proteines de fusion du mycobacterium tuberculosis
EP1328549A4 (fr) * 2000-10-03 2004-10-06 Human Genome Sciences Inc Recepteur hpraj70 de la proteine g specifique de la prostate humaine
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CA2443123A1 (fr) 2001-04-10 2002-10-24 Agensys, Inc. Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
US6897024B2 (en) 2001-05-31 2005-05-24 Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
JP2005505271A (ja) 2001-09-06 2005-02-24 アジェンシス， インコーポレイテッド 癌の処置および検出において有用なｓｔｅａｐ−１と名称が与えられる核酸および対応するタンパク質
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
DE60313163T2 (de) * 2002-06-11 2008-01-03 Glaxosmithkline Biologicals S.A. Immunogene zusammensetzungen
WO2004016733A2 (fr) 2002-08-16 2004-02-26 Agensys, Inc. Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
AU2004209578A1 (en) 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
EP1636379A2 (fr) * 2003-06-26 2006-03-22 Exonhit Therapeutics S.A. Genes specifiques de la prostate et leur utilisation comme cibles dans le traitement et le diagnostic du cancer de la prostate
BRPI0418766B8 (pt) 2004-04-22 2021-05-25 Agensys Inc anticorpo ou seu fragmento, vetor, composição farmacêutica, ensaio e método para detectar a presença de proteína steap-1, bem como método para distribuir um agente citotóxico ou um agente de diagnóstico
CA2491067A1 (fr) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Rapport entre arnm dans les sediments urinaires ou l'urine en tant que marqueur pronostique du cancer de la prostate
ES2636089T3 (es) 2006-10-27 2017-10-05 Genentech, Inc. Anticuerpos e inmunoconjugados y usos para los mismos
GB201513921D0 (en) 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
CA3055132A1 (fr) 2017-04-03 2018-10-11 F. Hoffmann-La Roche Ag Anticorps se liant a steap-1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041289A (en) * 1987-11-13 1991-08-20 Becton Dickinson And Company Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
KR19990087802A (ko) * 1996-03-15 1999-12-27 길리스 스티브 전립선암의 면역치료 및 면역진단을 위한 화합물 및 방법
US6887660B2 (en) * 1997-02-25 2005-05-03 Corixa Corporation Compounds for immunodiagnosis of prostate cancer and methods for their use
PL196260B1 (pl) * 1997-02-25 2007-12-31 Corixa Corp Polipeptyd, cząsteczka DNA, komórka gospodarza, białko fuzyjne, kompozycje farmaceutyczne i szczepionki do leczenia raka prostaty
US6130043A (en) * 1997-05-02 2000-10-10 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
AU4823599A (en) * 1998-06-22 2000-01-10 Incyte Pharmaceuticals, Inc. Prostate cancer-associated genes
EP1870466A3 (fr) * 1998-07-14 2008-03-19 Corixa Corporation Compositions et procédés pour le traitement et le diagnostic du cancer de la prostate
AU7994200A (en) * 1999-10-04 2001-05-10 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer

Similar Documents

Publication Publication Date Title
JP2004537252A5 (fr)
Kiyono et al. NALT-versus Peyer's-patch-mediated mucosal immunity
Fallarino et al. Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo
AU749544B2 (en) Tumor antigen peptides originating in cyclophilin B
ES2373055T3 (es) Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno.
EP2626081B1 (fr) Contrôle immunogène de tumeurs et cellules tumorales
JP2005504513A5 (fr)
CN102174479B (zh) 靶向性治疗人肿瘤的溶肿瘤腺病毒及其应用
JP2002505843A5 (fr)
CA2245702A1 (fr) Antigene du cancer humain de proteine 1 et 2 apparentee a la tyrosinase et genes le codant
CA2361009A1 (fr) Proteines de fusion her-2/neu
JP2020502262A5 (fr)
JP2006515749A5 (fr)
IL142905A0 (en) Functional antagonists of hedgehog activity
JP2001516226A (ja) 腫瘍関連性の抗原に対する免疫応答を誘導するための組成物および方法
CA2262756A1 (fr) Ligand associe a un facteur de necrose tumorale
UA79235C2 (en) Il-18 mutant polypeptide, extracted dna coded il-18 mutant polypeptide, vector and pharmaceutical composition
Colluru et al. Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses
JP2002512800A5 (fr)
CN106810610A (zh) 抗EpCAM和CD3特异性双靶向抗体及其制备方法和应用、含该双靶向抗体表达盒的微环DNA及应用
NZ333203A (en) Tumour antigen proteins, genes thereof, and tumour antigen peptides
CN115850506A (zh) 一种cd4辅助性t细胞表位融合肽及其疫苗
CA2522994A1 (fr) Acides nucleiques et proteines correspondantes appelees 109p1d4 utiles dans le traitement et la detection du cancer
JP2003529608A5 (fr)
WO2017035251A1 (fr) Lymphocytes t modifiés pour surexprimer la c-myb